Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice
Immunotherapy has expanded treatment options for cancers with historically poor outcomes, yet a significant proportion of patients still fail to achieve durable clinical benefit. We defined the contribution of β-adrenergic receptor (βAR) signaling, a component of the stress response, on success of i...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2018-03-01
|
| סדרה: | OncoImmunology |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1080/2162402X.2017.1405205 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|